IL2 and neoplasm: We therefore used the rapid expansion protocol (REP [Besser et al, 2010; Dudley et al, 2010]), which for the first 2 wk of culture (pre-REP) uses only the addition of recombinant human IL-2 for TIL expansion from tumor digests (Berg et al, 2020; Rohaan et al, 2022).